Table 3.
Study | Population | No. of Patients | Comparison | Success (%) | AUROC for liver fibrosis stage: |
Any significant differences, p<0.05 |
|||
---|---|---|---|---|---|---|---|---|---|
≥ 2 | ≥ 3 | 4 | |||||||
Studies directly comparing VCTE and 2D MRE | |||||||||
Chen et al., 2017 | Mixed | 111 | VCTE | 81% | 0.91 | 0.87 | 0.92 | 2D MRE higher rate of success and reliability than VCTE | |
2D MRE | 96% | 0.93 | 0.92 | 0.95 | |||||
Park et al., 2017 | NAFLD | 104 | VCTE | 93% | 0.86 | 0.80 | 0.69 | 2D MRE more accurate at diagnosing stage ≥ 1 than VCTE (0.82 vs. 0.67) | |
2D MRE | 100% | 0.89 | 0.87 | 0.87 | |||||
Imajo et al., 2016 | NAFLD | 142 | VCTE | 89% | 0.82 | 0.88 | 0.92 | 2D MRE more accurate at diagnosing stage ≥ 2 than VCTE | |
2D MRE | 100% | 0.89 | 0.89 | 0.97 | |||||
Studies directly comparing pSWE and 2D MRE | |||||||||
Chou, Chen, Wu, Lin, & Chen, 2017 | HCC (mixed etiology) | 82 | pSWE | 100% | 0.81 | 0.86 | 0.86 | 2D MRE more accurate at diagnosing stage ≥ 2, ≥ 3, and 4 than pSWE |
|
2D MRE | 98% | 0.93 | 0.96 | 0.99 | |||||
Cui et al., 2016 | NAFLD | 125 | pSWE | 98% | 0.85 | 0.90 | 0.86 | 2D MRE more accurate at diagnosing stage ≥ 1 than pSWE | |
2D MRE | 99% | 0.89 | 0.93 | 0.88 |
VCTE Vibration-controlled transient elastography, pSWE point shear wave elastography, 2D SWE two-dimensional shear wave elastography, 2D MRE two-dimensional magnetic resonance elastography, NAFLD nonalcoholic fatty liver disease, HCC hepatocellular carcinoma.